|
Volumn 91, Issue 5, 2007, Pages 566-567
|
Topical azithromycin: New evidence?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
AZITHROMYCIN;
TETRACYCLINE;
BLINDNESS;
CHLAMYDIASIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DISEASE TRANSMISSION;
DRUG COST;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
EDITORIAL;
EVIDENCE BASED MEDICINE;
EXTERNAL VALIDITY;
HEALTH PROMOTION;
HUMAN;
INTERVENTION STUDY;
MEDICAL EDUCATION;
MEDICAL ETHICS;
PREVALENCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TRACHOMA;
TREATMENT DURATION;
WORLD HEALTH ORGANIZATION;
ANTI-BACTERIAL AGENTS;
AZITHROMYCIN;
HUMANS;
TRACHOMA;
|
EID: 34248142836
PISSN: 00071161
EISSN: None
Source Type: Journal
DOI: 10.1136/bjo.2006.107102 Document Type: Editorial |
Times cited : (6)
|
References (10)
|